 Data from each patient will be collected after informed consent is signed inclusion visit, and will include retrospective information from the start of aripiprazole once-monthly treatment initiation index date until the follow-upinclusion visit minimum of 6 months after the index date. Data will be retrospectively collected from all visits occurring as per clinical practice usually once monthly. 